Wave Life Sciences News Today

Yet a whole generation of people did realize, they did, that you shouldnt take on too much debt. That you should live within your means, you shouldnt recklessly flip houses or create Financial Instruments no one can understand its a bad idea to take out loans youll never be able to repay. Its an even worse idea for the banks to write those kinds of loans. Look, people, it is just a fact. We got more frugal in this country. We got less reckless in this country. We got more prudent. The same way t...

Platinum Investment Management Ltd. boosted its stake in Wave Life Sciences Ltd. (NASDAQ:WVE – Free Report) by 43.9% during the 4th quarter, HoldingsChannel.com reports. The fund owned 655,331 shares of the company’s stock after purchasing an additional 200,000 shares during the period. Platinum Investment Management Ltd.’s holdings in Wave Life Sciences were worth $3,309,000 as […]

Platinum Investment Management Ltd. grew its stake in shares of Wave Life Sciences Ltd. (NASDAQ:WVE – Free Report) by 43.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 655,331 shares of the company’s stock after buying an additional 200,000 shares during the quarter. […]

BioPharma

Monashee Investment Management LLC bought a new position in shares of Wave Life Sciences Ltd. (NASDAQ:WVE – Free Report) in the 4th quarter, according to its most recent 13F filing with the SEC. The fund bought 103,300 shares of the company’s stock, valued at approximately $522,000. Several other institutional investors also recently modified their holdings […]

/PRNewswire/ -- DelveInsights Stuttering Market Insights report includes a comprehensive understanding of current treatment practices, stuttering emerging...

The anticipated introduction of new therapeutic options could lead to an expansion of the market for stuttering treatment during the forecast period. This growth may be fueled by factors such

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of...

Wells Fargo & Company started coverage on shares of Wave Life Sciences (NASDAQ:WVE – Free Report) in a report released on Wednesday, MarketBeat.com reports. The firm issued an overweight rating and a $11.00 price target on the stock. Other analysts have also recently issued research reports about the stock. StockNews.com cut shares of Wave Life […]

Wave Life Sciences Ltd. (NASDAQ:WVE – Get Free Report)’s stock price was down 6.2% during mid-day trading on Monday . The stock traded as low as $5.75 and last traded at $5.76. Approximately 539,734 shares were traded during trading, a decline of 35% from the average daily volume of 831,470 shares. The stock had previously […]